Holistic Integrative Oncology

Published by Springer

Open access · CC BY · In DOAJ · Singapore · Cancer Immunotherapy and Biomarkers

Journal at a glance

ISSN

2731-4529

Publisher

Springer

Country

Singapore

Language

en

License

CC BY

Also known as: Holist Integr Oncol (Abbreviation)

Indexing

• DOAJ: Active
• Scopus: Indexed

Metrics

Subjects

• Cancer Immunotherapy and Biomarkers
• Gastric Cancer Management and Outcomes
• Lung Cancer Treatments and Mutations
• Esophageal Cancer Research and Treatment
• Cancer Genomics and Diagnostics
• Head and Neck Cancer Studies
• Hepatocellular Carcinoma Treatment and Prognosis
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Perioperative stress–inflammation–immunosuppression axis and tumor progression: mechanistic integration and anesthetic management strategies (2026)
• “Jun-Chen-Zuo-Shi” - the Chinese medical perspective on clinical oncology nutritional therapy (2026)
• Cell-based and cell-derived strategies for anticancer therapy-related renal injury: progress, challenges, and translational perspectives (2026)
• Neoadjuvant chemotherapy combined with immunotherapy in selected limited-stage small-cell lung cancer: a retrospective real-world study (2026)
• Efficacy and safety of surufatinib plus PD-1/PD-L1 inhibitors as first-line maintenance therapy in extensive-stage small cell lung cancer (2026)

Similar journals

• Japanese Journal of Clinical Oncology — Japan · — · Same subject: Esophageal Cancer Research and Treatment, Same subject: Gastric Cancer Management and Outcomes, 4 shared subjects in total
• In Vivo — Greece · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Gastric Cancer Management and Outcomes, 4 shared subjects in total
• Annals of Surgical Oncology — United States · — · Same subject: Esophageal Cancer Research and Treatment, Same subject: Gastric Cancer Management and Outcomes, 3 shared subjects in total
• Journal of Cancer Research and Clinical Oncology — Germany · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Hepatocellular Carcinoma Treatment and Prognosis, 3 shared subjects in total
• ESMO Open — Kingdom of the Netherlands · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 3 shared subjects in total
• Cancer Discovery — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 3 shared subjects in total

Sources: DOAJ, NLM Catalog, OpenAlex, Crossref, Scopus

Author guidelines